chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per progress note of 5/13/2010: I have been itching and have rash all over body, the only thing I think it might be was the H1N1 vaccine, I had on Tuesday, I started breaking out in rash really bad yesterday and the itching is really getting to me. Patient had light red raised rash thru-out trunk, bilateral legs and arms. No drainage noted from site. Patient told nurse that he had H1N1 vaccine when he was in clinic on 5/11/10 and that would be the only new product he had used, denied any new meds., food, detergent or clothes. Prednisone 20 mg every day, oatmeal PRN.
Information has been received from a physician concerning an approximately 14 year old patient who on an unspecified date was vaccinated with the first dose of GARDASIL vaccine. It was reported that after received the first dose of GARDASIL vaccine, in two instances, the patient experienced more of a general rash after getting vaccine. It was reported that the patient did not continued with the series. So, the patient only received the first dose. The patient's outcome was not reported. This is one of two patients concerning the same source. Additional information has been requested.
Right side Neck lymph node swelled shortly after vaccination now in process of ultrasound, ct.  scan, biopsy performed and mass on right side of neck that they want to remove for further testing. This has all took place shortly after I received Moderna!
Information has been received from a registered nurse concerning a 12 month old female with no pertinent medical history of known allergies who on 08-APR-2008 was vaccinated with her first dose of  VARIVAX (Oka/Merck) (lot# 659357/1567U). On 28-APR-2008 an onset of symptoms began with sores that developed in the patient's private area and sores on her head. There was no fever, decreased appetite and the patient was diagnosed with varicella. The patient was seen in the physician's office for medical attention. No labs or diagnostic studies were performed. No treatment was noted. The child was noted to be recovering but still had spots. No other information reported. There was no product quality complaint. Additional information has been requested.
pt experienced lightheadedness, flushing and trouble breathing. The pt was walking around the store during her 15 minutes of observation and decided to walk to her car once symptoms became present. She did not report back to the pharmacy. No treatment was given ans the pharmacy was told about the reaction 4 days after it was given
Erythema of left deltoid from left shoulder to half of left upper arm.  Minimal swelling.
This spontaneous report as received from a registered nurse refers to a 7 years old and 11 month old female patient. On unknown dates, the patient received 3 doses of GARDASIL (dose, route and lot # not reported) when she was 7 year 11 month, 8 year 2 months, and 8 year and 4 month old when the patient was in a different country. The name of the country was unknown. No concomitant medication was reported. No adverse effect was reported. Additional information has been requested.
Heart failure; was scheduled for her second dose, but was unable to get it because she was hospitalized; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CARDIAC FAILURE (Heart failure) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Heart disorder (heart condition) and Blood pressure high.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-May-2021, the patient experienced CARDIAC FAILURE (Heart failure) (seriousness criteria hospitalization and medically significant). On 11-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (was scheduled for her second dose, but was unable to get it because she was hospitalized). The patient was hospitalized from 09-May-2021 to 13-May-2021 due to CARDIAC FAILURE. On 11-May-2021, PRODUCT DOSE OMISSION ISSUE (was scheduled for her second dose, but was unable to get it because she was hospitalized) had resolved. On 13-May-2021, CARDIAC FAILURE (Heart failure) outcome was unknown.            The patient's concomitant medications included unspecified high blood pressure pills and heart pills. Treatment information was not provided.  Very limited information regarding this event has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
I had insomnia and a low grade fever. I also had pain and swelling at the injection site and fatigue.  These symptoms began as at about 8:45 PM on 04/15/2021.  I took 325 mg acetaminophen tablet at 09:00 PM and  02:00 AM.  This helped reduce my fever and pain.
Injection site on left arm sore,warm to touch and redness all around the injection site; Injection site on left arm sore,warm to touch and redness all around the injection site; Injection site on left arm sore,warm to touch and redness all around the injection site; The initial case was missing the following minimum criteria: no adverse effect. Upon receipt of follow-up information on 07Feb2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer. A 70-year-old female patient (Non-pregnant) received second dose of bnt162b2 (BNT162B PFIZER-BIONTECH, COVID-19 Vaccine, Solution for injection, Lot Number: EL9269, Expiration date: Not reported), via an unspecified route of administration, administered in Arm Left on 05Feb2021 (at the age of 70-years-old) as single dose for COVID-19 immunization. Medical history included Known allergies: penicillin. Concomitant medications were not reported. The patient previously took cefalexin monohydrate (KEFLEX [CEFALEXIN]), sulfamethoxazole trimethoprim (BACTRIM). The patient historical vaccine includes BNT162B2, received first dose Lot number: EL3246, administration date: 15Jan2021, vaccine location: Left arm. On 05Feb2021 patient experienced injection site on left arm sore, warm to touch and redness all around the injection site. Patient was not tested COVID positive post vaccination. The outcome of the events was recovering.   Information on the lot/batch number has been requested.  Follow-up (07Feb2021): New information received from same contactable consumer includes: Events, second dose, Known allergies and Lot No. were updated.
p/vax pt had 20cmx15cm bright red erythema & edema lesion
DIZZY; CHILLS; HEADACHE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced dizzy, chills, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dizzy, headache and chills was not reported. This report was non-serious.
She had a bad reaction after her first Moderna Covid-19 vaccine; Mostly bed bound; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (She had a bad reaction after her first Moderna Covid-19 vaccine) and BEDRIDDEN (Mostly bed bound) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Myalgic encephalomyelitis (chronic disease) and Multi-organ disorder (create problem with energy delivery to cells).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (She had a bad reaction after her first Moderna Covid-19 vaccine) and BEDRIDDEN (Mostly bed bound). At the time of the report, IMMUNISATION REACTION (She had a bad reaction after her first Moderna Covid-19 vaccine) and BEDRIDDEN (Mostly bed bound) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
pt had a positive COVID test on 8/30/21; pt passed away in a nursing home - Healthcare.
Within 24 hours of administration, patient had hives, lip swelling 3 different occasions that were brief until the last occasion and the swelling did not resolve.
ear   Ear Ache and now pain in the canal down to the throat Treated with Tylenol     ache
er visit turned into a hospital stay in  ICU....due to blood clots that were in the lungs that were so pervasive a heart attack ensued due to the pressure from the lungs
Hard to breathe with simple walking starting the morning after 2nd vaccine. 3/8 couldn?t work due to breathing issues, 3/9 couldn?t work and called pcp but told to wait it out. 3/16 in person with pcp and ran labs, 3/23 saw hematology to double check blood, symptoms worse advised to go to ER. Admitted on 3/23 with afib and discharged 3/28 with spontaneous conversion.
The day before his 5 year check-up, he was a little concerned about getting his immunizations.  Mom yelled at him for picking his nose.  In the office, he tolerated having the immunizations and didn't seem upset when he got them.  2 days after receiving MMR, DTaP, and IPV he developed severe obsessive thoughts about killing dad, hurting mom, and getting dirty.  He was afraid to use a knife or fork because he might hurt someone with it. He could not watch cartoons because they were too violent and made him have bad thoughts.  He felt compulsions to call people names and stick his tongue out at them.  He cried a lot.  He knew the thoughts were wrong, but he couldn't get them out of his head and was very disturbed by them.  No auditory or visual hallucinations.  Excessive nose wiping because he was afraid that there was a booger on it.  Wiping hands constantly.  Had a baseline of being a worrier but nothing like this.  Father has anxiety disorder.  Patient started on celexa.  Symptoms slowly improved after 2 weeks on celexa.  Gone by a month.  Weaned off celexa in 6/04.  No symtoms or relapse.  Attempted to get patient to see psychiatrist given family history of anxiety.  Could not get a psychiatrist to see patient. Mom and dad feel it was immunization reaction rather than underlying anxiety disorder exacerbation.
Facial edema.  07/17/2007 MR received for admission 3/18-22/2007 for c/o persistant high fever. Pt initially developed eye swelling and an erythematous rash around his eyes.  The following day erythema and swelling of the L hand and fingers were noted which then progressed to involve the entire forearm.  Fever developed and child was seen outpt for possible cellulitis vs allergic rxn vs immunization reaction and then admitted. Child had resolution of rash and swelling with IV abx however fever persisited.   Consultation noted maculopapular eruption of a countable # of lesions on arms and legs. Assessment:  Fever and rash possibly due to a Varivax reaction with 2' strep invasion.  S/P Kawasaki disease, cannot r/o reactivation of that.  Eosinophilia, perhaps c/w an allergic rxn. Principal DX:  Resolved cellulitis of the L forarm and probable allergic rxn vs immunization reaction.
covid_test_name_post_vaccination= RT-PCR, covid_test_date= 29Jan2021, covid_test_result= Positive; Itching soft palate area; Itching in ears; mild respiratory trouble; This is a spontaneous report received from a contactable health care professional (patient) and from a Pfizer sponsored program. A 44-year-old female patient of received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9261) left arm on 22Jan2021 at 17:45 (at the age of 40-years-old) via intramuscularly at single dose on the unspecified anatomical location for COVID-19 immunization. Relevant medical history included asthma and psoriasis. The patient had known allergy to penicillin. The patient did not receive any other vaccine in four weeks. The patient was not pregnant at the time of vaccination. Concomitant medications included fluticasone propionate (FLOVENT), ethinylestradiol,/levonorgestrel (SRONYX) and cetirizine. On the same date, two hours (at 19:00) after administration of first dose the patient had Itching soft palate area, itching in ears and mild respiratory trouble. The patient received treatment with diphenhydramine 25mg. On 29Jan2021, nasal swab RT-PCR COVID test was positive for the patient. Outcome of the events Itching soft palate area, itching in ears and mild respiratory trouble was recovered while outcome of the event was unknown. The action taken in response to the event(s) for BNT162B2 was not applicable.
Injection given very high on left shoulder. When injection started?burning pain went through the shoulder and then followed bloodflow down left arm to fingers, back up arm, down left side of back of neck, down the back, down the back of the left leg to foot, and back up to the middle of body before the burning no longer followed a path. Upon standing, I was dizzy, and told the pharmacist, and I told her that something felt wrong. She asked me to wait outside the pharmacy, standing, for 10 minutes. I was shivering and visibly shaking. Immediately after the injection, the burning on the left side persisted for over 30 min, and was over the whole left side of my body.  I could not move my shoulder joint without a lot of pain. The pain has gotten worse each day, around the shoulder.....pain in the rest of my body has lessened.
PATIENT STATED HER ARM HURT AFTER THE PREVNAR13 WAS GIVEN AND STILL HURTS TODAY. SHE SAID THE PAIN IS NOT AS BAD AS WHEN SHE FIRST GOT THE VACCINE, BUT SHE SAID IT'S STILL SORE. SHE SAID THERE IS NO REDNESS, NO SWELLING, NO FEVER, AND SHE IS ABLE TO MOVE HER ARM BUT IT STILL HURTS BUT IS GETTING BETTER. SHE HAS AN APPOINTMENT WITH HER DR ON APRIL 26TH FOR HER REGULAR VISIT AND WILL CONSULT WITH DR. I ADVISED HER TO CALL DR IF HER ARM DOES NOT GET BETTER OR HURTS MORE OR SHE STARTS TO GET A FEVER. I ALSO CALLED DR'S OFFICE TO NOTIFY HIM OF HER ADVERSE EVENT.
cried with sudden onset seconday p/given inject cont to cry for 1 1/2-2 hrs lt leg swollen & red; no temp; pt given DPH & APAP;
This is a spontaneous report from a contactable unspecified healthcare professional. This 4-month-old male patient of unknown ethnicity received PREVNAR 13 (Lot# 32487, Exp. Date: Dec2014) at 0.5 ml single dose in the left thigh at 12:10 hr on 17May2013. The relevant medical history was none. The relevant concomitant medication included HIB vaccine (Mfg by Sanofi, lot # UH770AA) Intramuscular in the right thigh, at an unknown dose and frequency on unknown date in 2013 for an unknown indication, the second dose of which (Sanofi, lot # UH770AA) was given on 17May2013 in the right thigh. On 17May2013 the consumer experienced redness around the injection site and on an unknown date in May2013 the patient experienced a rash at the injection site which covered upper part of the leg, after he was given his 4 month dose of PREVNAR 13. The relevant laboratory data was none. The last action taken with PREVNAR 13 therapy was unknown. Therapeutic measures taken in response to the reported events were none. The consumer had not recovered from the reported events at the time of report. This child had on an unspecified date an injection site reaction with PEDIARIX and HIB vaccine. Outcome of the event was unknown. Follow Up (20May2013): New information reported from a contactable medical assistant calling from a physician office, who reported for a consumer, includes: patient ethnicity: PREVNAR 13 data; medical history none; concomitant medication; new event; laboratory data was none; events outcome; birth weight. Follow-up (28-JUN-2013) Follow-up attempts completed. No further information expected.
Infection at injection site. Patient went to urgent care for swelling and redness, fever, body ache, and headache. Patient was prescribed Keflex 2,000mg twice a day and ibuprofen for pain and swelling.
Arm pain the first two days. Red raised warm rash. Oval swelling from top of arm to elbow.
On Wednesday 02/03/2021 injection site was really itchy, now she has a large round red mark around the injection site and the area is swollen.
1 of 3 pt recv vax from the same TD lot# & exp a local rxn;rxn described as swelling @ inj site;recovered
Fortunately, I was not having chest pains. I went into the emergency for right leg, it was very swollen. They did a CAT scan of my lungs and found that I had blood clots in my lungs. They ordered an ultrasound for my right leg and found that I had DVT. I was then admitted to the hospital. A cardiovascular surgeon was brought in, I did have surgery and was released on Tuesday. I am now giving myself shots of Lovenox twice a day for a while and taking Clopidogrel to help thin my blood to help keep me from getting another blood clot as well as dissolve the ones in my lungs.
patient got it and been sicker then crap for 2 weeks; Initial information received on 13-Nov-2020 regarding an unsolicited valid non-serious social media case received from a consumer.  This case involves a patient who got sicker then crap for 2 weeks (illness), while she received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On an unknown date,the patient received a dose  of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, patient got sicker then crap for 2 weeks (illness) (Unknown latency) following the administration of INFLUENZA VACCINE and been isolating for at least that long no call back for covid test so taking it as negative.  Relevant laboratory data was not reported.  It was not reported if the patient received any corrective treatment.  The outcome was unknown for event.  There will be no information available on the batch number for this case.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2013, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On an unknown date in 2016, the patient was treated at an urgent care center for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Hard knot (golf ball sized) 1 - 2 hours after injection. Next morning upper left arm swelled to twice normal size. Bicep muscle clearly outlined in red itchy rash moving down forearm. That evening urgent care clinic diagnosed with allergic reaction and infection - steroids and antibiotics prescribed to clear out infection and reaction. 3 days later rash still visible and bicep muscle outlined in bruising of skin.
This spontaneous report as received from a registered nurse refers to a 1 year old male patient with no known allergies. On 28-MAY-2013 the patient was vaccinated with PROQUAD (Merck) 0,5 ml (subcutaneously, left thigh, lot number H020854, exp. date 26-MAY-2014). Concomitant therapies included albuterol sulfate(manufacturer unknown). On 19-JUN-2013 the patient experienced chickenpox-like rash all over and fever. The patient sought medical attention and visited office. No treatment was given. None of lab diagnostics were performed. The outcome of events reported was as not recovered/not resolved. Relatedness between vaccination with PROQUAD (Merck) and events was unknown. Additional information has been requested.
Pain at site with Fever (temp. 101 degrees F). Patient was sent to the local hospital ER and returned to the facility with a diagnosis of Fever post vaccination. Tylenol was given and patient received IV HEP saline at the ER.
Had to go to ER - diagnosed with "severe reaction" to immunization/cellulitis. 7 inch area around injection site red, inflamed, warm to touch, sore and burning. Patient felt lethargic. Vaccinated on Thurs - that Sat. went to ER.
Patient stated that since his vaccination on 3/7/18 his arm has been sore. No changes in motility, no redness or swelling.
My entire left side of my body was numb and didn't subside for 2-3 hours.
Out of breathe, asthma, fatigued arm (same as one I got shot in)
2:00 on 30JUL pt choking-stiff, sz, eyes rolled back, turn blue-no fever;MD @ 4:00-no fever;another one @ 8PM;
injection site pain; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 61-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional case details were reported as follows: This case was reported by patient. The age at vaccination was not reported. For tolerance of 2nd dose, refer case US2019AMR209758.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site numbness in a patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site numbness and injection site tingling. On an unknown date, the outcome of the injection site numbness and injection site tingling were unknown. It was unknown if the reporter considered the injection site numbness and injection site tingling to be related to SHINGRIX. Additional details were provided as follows: This case was received via click to chat. The age at vaccination was not reported. No additional information was provided. The pharmacist would not give out demographic background and other information. This case has been linked to US2018GSK057093, reported by the same reporter for the patient who also experienced same adverse events.
Headache, Sedation, Myalgia, Arthralgia, NauseaVomiting,  chills and fatigue. pain at the injection site.
The next day after receiving the shot he woke up with chills a sore throat and very achy. He was like that for about a day then the next day his throat was very sore and could hardly talk. Now this morning he woke up with a huge red type sore on his left side same arm that he got the shot on.